A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients
Open Access
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Annals of Hepatology
- Vol. 11 (2) , 179-185
- https://doi.org/10.1016/s1665-2681(19)31022-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chronic Hepatitis C InfectionNew England Journal of Medicine, 2011
- Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menHepatology, 2011
- Boceprevir for Untreated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency VirusAmerican Journal of Gastroenterology, 2009
- Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based TherapyCanadian Journal of Gastroenterology and Hepatology, 2009
- Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative AnalysisAmerican Journal of Transplantation, 2006
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort studyHepatology, 2001
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001